Heart failure in Asia: The present reality and future challenges

European Heart Journal, Supplement

Volumn 14, Issue SUPPL. A, 2012, Pages

  Lee, Sheldon ^a   Khurana, Roht ^b,c   Leong, Kui Toh Gerard ^a  

^a CHANGI GENERAL HOSPITAL   (Singapore)

^b DEPARTMENT OF CARDIOLOGY   (Singapore)

^c NATIONAL UNIVERSITY OF SINGAPORE   (Singapore)

Author keywords

[No Author keywords available]

Indexed keywords

ALDOSTERONE ANTAGONIST; BETA ADRENERGIC RECEPTOR BLOCKING AGENT; DIGOXIN; DIPEPTIDYL CARBOXYPEPTIDASE INHIBITOR; DIURETIC AGENT; HYDRALAZINE; ISOSORBIDE;

ARTICLE; ASIA; DEFIBRILLATION; HEART FAILURE; HEART REHABILITATION; HEART TRANSPLANTATION; HUMAN; PREVALENCE; PRIORITY JOURNAL; QUALITY OF LIFE; SEX DIFFERENCE;

EID: 84863233448     PISSN: 1520765X     EISSN: 15542815     Source Type: Journal    
DOI: 10.1093/eurheartj/sur037     Document Type: Article

References (10)

1. Huffman MD, Prabhakaran D. Heart failure: Epidemiology and prevention in India. Natl Med J India 2010;23:283-8.
2. Jiang H, Ge J. Epidemiology and clinical management of cardiomyopathies and heart failure in China. Heart 2009;95:1727-1731.
3. Cohn JN, Archibald DG, Ziesche S, Franciosa JA, Harston WE, Tristani FE, Dunkman WB, Jacobs W, Francis GS, Flohr KH, Goldman S, Cobb FR, Shah PM, Saunders R, Fletcher RD, Loeb HS, Hughes VC, Baker B. Effect of vasodilator therapy on mortality in chronic congestive heart failure results of a veterans administration cooperative study (V-HEFT I). N Engl J Med 1986;314:1547-1552. (Pubitemid 16114684)
4. Dickstein K. ESC Guidelines for the diagnosis and treatment of acute and chronic heart failure 2008: The Task Force for the Diagnosis and Treatment of Acute and Chronic Heart Failure 2008 of the European Society of Cardiology. Developed in collaboration with the Heart Failure Association of the ESC (HFA) and endorsed by the European Society of Intensive Care Medicine (ESICM). Eur Heart J 2008;29: 2388-2442.
5. Thompson DR, Yu CM. Cardiovascular Prevention and Rehabilitation.1st ed. Philadelphia, PA: Springer; 2007: Chap 10.
6. Yu CM, Hayes DL, Auricchio A. Cardiac Resynchronization Therapy. Hoboken, NJ: Wiley-Blackwell; 2008.
7. Jessup M, Abraham WT, Casey DE, Feldman AM, Francis GS, Ganiats TG, Konstam MA, Mancini DM, Rahko PS, Silver MA, Stevenson LW, Yancy CW. 2009 focused update: ACCF/AHA guidelines for the diagnosis and management of heart failure in adults: A Report of the American College of Cardiology Foundation/American Heart Association Task Force on Practice Guidelines Developed in Collaboration With the International Society for Heart and Lung Transplantation. J Am Coll Cardiol 2009;53:1343-1382.
8. Sivathasan C. Heart transplantation in Singapore. Ann Acad Med Singapore 2009;38:309-14.
9. Wu EB, Yu CM. Management of diastolic heart failure: A Practical Review of Pathophysiology and Treatment Trial Data. Int J Clin Pract 2005;59:1239-1246. (Pubitemid 43904533)
10. Esler MD, Krum H, Sobotka PA; the Symplicity HTN-2 Investigators. Renal sympathetic denervation in patients with treatment-resistant hypertension (the Symplicity HTN-2 Trial): A randomised controlled trial. Lancet 2010;376:1903-1909.